MOR23 deficiency exacerbates hepatic steatosis in mice
The FASEB Journal · 2024
DOI: 10.1096/fj.202401468rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Wesuk Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutrition, BK21 FOUR, Yonsei University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Diet, High-Fat, Fatty Liver, Receptors, Odorant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Hepatic steatosis, a common liver disorder, can progress to severe conditions such as nonalcoholic steatohepatitis and cirrhosis. While olfactory receptors are primarily known for detecting odorants, emerging evidence suggests that they also influence liver lipid metabolism. This study generated a mouse model with a specific knockout of olfactory receptor 23 (MOR23) to investigate its role in hepatic steatosis. MOR23 knockout mice on a normal diet showed a slight increase in liver weight compared to wild‐type (WT) mice. When fed a high‐fat diet (HFD), these knockout mice exhibited accelerated hepatic steatosis, indicated by increased liver weight and hepatic triglyceride levels. Our findings suggest that the cyclic adenosine monophosphate/protein kinase A/AMP‐activated protein kinase pathway is involved in the role of MOR23, leading to the upregulation of peroxisome proliferator‐activated receptor α, peroxisome proliferator‐activated receptor‐γ coactivator 1‐α, and their target β‐oxidation genes in the liver. MOR23 also appeared to regulate lipogenesis and free fatty acid uptake in HFD‐fed mice, potentially by influencing sterol regulatory element‐binding protein 1 activity. Notably, administering a potential MOR23 ligand, cedrene, attenuated hepatic steatosis in WT mice, but these effects were largely nullified in MOR23 knockout mice. These findings provide valuable insights into the in vivo role of MOR23 in hepatic steatosis development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food and Nutrition, BK21 FOUR, Yonsei University, Seoul, Republic of Korea.
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Gemcro, Inc., Seoul, Republic of Korea.
ORCID-Profile: Wesuk Kang, Suhjin Yang, Jiyun Roh, Dabin Choi, Han-Woong Lee, Jae Hoon Lee, Taesun Park
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Kang, W., Yang, S., Roh, J., Choi, D., Lee, H. W., Lee, J. H., & Park, T. (2024). MOR23 deficiency exacerbates hepatic steatosis in mice. The FASEB Journal. https://doi.org/10.1096/fj.202401468rr
Vancouver
Kang W, Yang S, Roh J, Choi D, Lee HW, Lee JH, et al. MOR23 deficiency exacerbates hepatic steatosis in mice. The FASEB Journal. 2024. doi:10.1096/fj.202401468rr
BibTeX
@article{Kang2024,
author = {Kang, Wesuk and Yang, Suhjin and Roh, Jiyun and Choi, Dabin and Lee, Han-Woong and Lee, Jae Hoon and Park, Taesun},
title = {MOR23 deficiency exacerbates hepatic steatosis in mice},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202401468rr}
}
EUVIMED